Why the ResMed (ASX:RMD) share price is up 7% to a record high

ResMed looks set to win from a key rival’s product recall…
The post Why the ResMed (ASX:RMD) share price is up 7% to a record high appeared first on The Motley Fool Australia. –

The ResMed Inc. (ASX: RMD) share price has started the week in fine form.

In afternoon trade, the sleep treatment focused medical device company’s shares are up 7.5% to a record high of $30.55.

Why is the ResMed share price shooting higher?

Investors have been scrambling to buy the company’s shares this morning following a favourable industry development.

On Monday global technology giant Philips announced that it would be voluntarily recalling 3.5 million ventilation devices for treating sleep apnoea. The majority of the affected devices within the advised five-year service life are in the first-generation DreamStation product family.

The release explains that despite a low complaint rate (0.03% in 2020), Philips determined based on testing that there are possible risks to users related to the polyester-based polyurethane (PE-PUR) sound abatement foam component in these devices.

The risks include the PE-PUR foam potentially degrading into particles which may enter the device’s air pathway and be ingested or inhaled by the user, and the foam may off-gas certain chemicals.

Philips CEO, Frans van Houten, said: “We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety.”

“In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution, which includes the deployment of the updated instructions for use and a comprehensive repair and replacement program for the affected devices. Patient safety is at the heart of everything we do at Philips.”

What now?

Given that repairs are expected to take several months to complete, the market appears to believe this will lead to an increase in demand for ResMed’s products, potentially allowing it to win market share from its rival.

The ResMed share price is now up 32% since this time last year.

The post Why the ResMed (ASX:RMD) share price is up 7% to a record high appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Why Isentia, Premier, ResMed, & Service Stream shares are racing higher

This ASX darling’s price is now ‘most attractive in 5 years’: analyst

2 quality ASX blue chip shares

Blue chip ASX healthcare share “really attractive”: top analyst

What I regret about my Afterpay (ASX:APT) shares: analyst

James Mickleboro does not own any shares mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!